Key result
Clinical clusters best predict 3-year major cardiovascular events in carotid endarterectomy patients, while plaque features reflect current symptoms.
Why the study?
Patients with carotid atherosclerosis have substantial heterogeneity in clinical presentation, plaque characteristics, and future cardiovascular risk, and it remained unclear which aspects of disease clinical variables, plaque morphology, and molecular profiles capture or how they relate to clinical outcomes.
Does unsupervised clustering of clinical, histological, and transcriptomic data improve stratification for current cerebrovascular symptoms and 3-year MACE in patients with carotid atherosclerosis undergoing carotid endarterectomy?
Cohort (n=1,075)
Does unsupervised clustering of clinical, histological, and transcriptomic data improve stratification for current cerebrovascular symptoms and 3-year MACE in patients with carotid atherosclerosis undergoing carotid endarterectomy?
Answers are grounded in this paper and cite their sources.
Clinical, histological, and transcriptomic clustering capture distinct and complementary aspects of carotid atherosclerosis, with clinical clusters best predicting future 3-year MACE and histological/transcriptomic clusters better reflecting current cerebrovascular symptoms and plaque biology.
AIMS: Patients with carotid atherosclerosis exhibit substantial heterogeneity in clinical presentation, plaque characteristics, and future cardiovascular risk, which do not always align. Clinical variables, plaque morphology, and molecular profiles are all used for patient stratification, yet it remains unclear which aspects of disease these data types capture and how they relate to clinically relevant outcomes. We therefore aimed to determine how clustering based on clinical, histological, and transcriptomic data relates to current cerebrovascular symptoms, plaque biology, and future cardiovascular risk. METHODS AND RESULTS: We analysed 1075 patients undergoing carotid endarterectomy with matched clinical, histological, and transcriptomic data. Unsupervised clustering was applied separately to each data modality, and resulting clusters were evaluated for overlap and association with current symptom status and 3-year major adverse cardiovascular events (MACE). Clusters derived from different modalities showed limited overlap, but distinct associations with clinical outcomes. Clinical clusters were most strongly associated with 3-year MACE, whereas histological and transcriptomic clusters were more closely related to current cerebrovascular symptoms. Transcriptomic clusters further delineated molecular pathways and plaque biology. Integration of modalities provided modest improvement in outcome stratification, indicating that these data types capture complementary rather than redundant information. CONCLUSION: Clinical, histological, and transcriptomic data capture distinct but complementary aspects of carotid atherosclerosis, reflecting systemic cardiovascular risk, local plaque phenotype, and underlying biology, with differing relevance to current cerebrovascular symptoms and future cardiovascular risk. The choice of data modality should therefore be guided by the intended clinical or biological question, rather than assuming a single approach can capture the full disease spectrum.
No takes yet. Share an insight, caveat, or question.
Wei et al. (2026) conducted a cohort in Carotid atherosclerosis (n=1,075). Unsupervised clustering based on clinical, histological, and transcriptomic data vs. Different data modalities compared against each other and in integration was evaluated on Current cerebrovascular symptom status and 3-year major adverse cardiovascular events (MACE). Unsupervised clustering in 1,075 carotid endarterectomy patients showed clinical clusters best predicted 3-year major cardiovascular events, while histological and transcriptomic clusters aligned with current symptoms.
Synapse has enriched 10 related papers. Consider them for comparative context: